When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 18, 2012.

Where is the headquarters located?

The headquarters is located at: Adamieckiego 13, 41-300 Dąbrowa Górnicza.

Who is on the management board?

The management board includes Paulina Owocka Podsiadło (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 6,000 (approx. $1,621).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

The company reported a revenue of $62,815 in 2024, which is a decrease of 10.1% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $7,646.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $21,713 in 2024, representing 42% of all operating expenses.

Merkuriussp. z o.o.

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2012-05-18

Share capital

6,000.00 PLN

Registered address

Adamieckiego 13, 41-300 Dąbrowa Górnicza, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 84 days for 2021).

2025not filed
202417/07/2025
202325/07/2024
202217/07/2023
202107/10/2022
202015/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Manufacture of pharmaceutical preparations196 / 258

Top 76%

Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations242 / 330

Top 73%

Sector · Manufacturing26,545 / 33,747

Top 79%

Voivodeship · Śląskie33,611 / 51,326

Top 65%

Country · Poland318,444 / 495,867

Top 64%

Results vs industry

Revenue

This companyUSD 62.81kMedianUSD 919.05kAverageUSD 25.83m

Net profit

This companyUSD 7.65kMedianUSD 14.92kAverageUSD 2.77m

Operating costs

This companyUSD 51.84kMedianUSD 873.06kAverageUSD 21.43m

Assets

This companyUSD 212.26kMedianUSD 897.46kAverageUSD 31.52m

Industry

Authorized Representatives

Janusz Ziętek – Management Board Member

Paulina Owocka Podsiadło – Management Board Member

Manner of representation

Each member of the management board acting independently is authorised to represent the company and submit declarations on its behalf.

Ownership

Owner	Shares	Share value	Stake
Paulina Owocka Podsiadłoage 42	3	$405.19	25%
Janusz Ziętekage 79	9	$1,215.56	75%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2012-06-25.

ING Bank Śląski
83 1050 1360 1000 0090 3010 1548
ING Bank Śląski
84 1050 1360 1000 0090 3010 1530

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Ti-Comsp. z o.o.	$157,549.77	ticomglobal.com
LideoS.A.	$95,067.91	lideo.tech
Munar PharmaS.A.	$85,649.72	munar.pl
BIO Animalisp. z o.o.	$49,176.96	proanimali.com
Ampliconsp. z o.o.	$48,330.99	amplicon.pl
Xenira Pharmaceuticalssp. z o.o.	$26,670.82	xenirapharma.com
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com
Bliss Pharmasp. z o.o.	$0.69	bliss-pharma.com